BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20200243)

  • 21. Global distribution, cross-species transmission, and receptor binding of canine parvovirus-2: Risks and implications for humans.
    Chen S; Shang K; Chen J; Yu Z; Wei Y; He L; Ding K
    Sci Total Environ; 2024 Jun; 930():172307. PubMed ID: 38599392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the evolutionary pattern of feline panleukopenia virus and canine parvovirus.
    Horiuchi M; Yamaguchi Y; Gojobori T; Mochizuki M; Nagasawa H; Toyoda Y; Ishiguro N; Shinagawa M
    Virology; 1998 Sep; 249(2):440-52. PubMed ID: 9791034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited transferrin receptor clustering allows rapid diffusion of canine parvovirus into clathrin endocytic structures.
    Cureton DK; Harbison CE; Cocucci E; Parrish CR; Kirchhausen T
    J Virol; 2012 May; 86(9):5330-40. PubMed ID: 22357278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferrin receptor binds virus capsid with dynamic motion.
    Lee H; Callaway HM; Cifuente JO; Bator CM; Parrish CR; Hafenstein SL
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20462-20471. PubMed ID: 31548398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-infection with feline and canine parvovirus in a cat.
    Battilani M; Balboni A; Giunti M; Prosperi S
    Vet Ital; 2013; 49(1):127-9. PubMed ID: 23564594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral Capsid, Antibody, and Receptor Interactions: Experimental Analysis of the Antibody Escape Evolution of Canine Parvovirus.
    López-Astacio RA; Adu OF; Goetschius DJ; Lee H; Weichert WS; Wasik BR; Frueh SP; Alford BK; Voorhees IEH; Flint JF; Saddoris S; Goodman LB; Holmes EC; Hafenstein SL; Parrish CR
    J Virol; 2023 Jun; 97(6):e0009023. PubMed ID: 37199627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of determinants of the host range for canine cells in the genome of canine parvovirus using canine parvovirus/mink enteritis virus chimeric viruses.
    Horiuchi M; Goto H; Ishiguro N; Shinagawa M
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1319-28. PubMed ID: 8207398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble form of canine transferrin receptor inhibits canine parvovirus infection in vitro and in vivo.
    Wen J; Pan S; Liang S; Zhong Z; He Y; Lin H; Li W; Wang L; Li X; Zhong F
    Biomed Res Int; 2013; 2013():172479. PubMed ID: 24089666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymmetric binding of transferrin receptor to parvovirus capsids.
    Hafenstein S; Palermo LM; Kostyuchenko VA; Xiao C; Morais MC; Nelson CD; Bowman VD; Battisti AJ; Chipman PR; Parrish CR; Rossmann MG
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6585-9. PubMed ID: 17420467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
    Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
    Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleavage of the transferrin receptor is influenced by the composition of the O-linked carbohydrate at position 104.
    Rutledge EA; Enns CA
    J Cell Physiol; 1996 Aug; 168(2):284-93. PubMed ID: 8707864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid.
    Parker JS; Parrish CR
    J Virol; 1997 Dec; 71(12):9214-22. PubMed ID: 9371580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New quantitative methods for detection of feline parvovirus (FPV) and virus neutralizing antibody against FPV using a feline T lymphoid cell line.
    Ikeda Y; Miyazawa T; Kurosawa K; Naito R; Hatama S; Kai C; Mikami T
    J Vet Med Sci; 1998 Aug; 60(8):973-4. PubMed ID: 9764414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ATP binding and hydrolysis on dynamics of canine parvovirus NS1.
    Niskanen EA; Ihalainen TO; Kalliolinna O; Häkkinen MM; Vihinen-Ranta M
    J Virol; 2010 May; 84(10):5391-403. PubMed ID: 20219935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the feline host range and a specific epitope of feline panleukopenia virus.
    Truyen U; Agbandje M; Parrish CR
    Virology; 1994 May; 200(2):494-503. PubMed ID: 7513918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking.
    Parker JS; Parrish CR
    J Virol; 2000 Feb; 74(4):1919-30. PubMed ID: 10644365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host-specific parvovirus evolution in nature is recapitulated by in vitro adaptation to different carnivore species.
    Allison AB; Kohler DJ; Ortega A; Hoover EA; Grove DM; Holmes EC; Parrish CR
    PLoS Pathog; 2014 Nov; 10(11):e1004475. PubMed ID: 25375184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence.
    López-Bueno A; Rubio MP; Bryant N; McKenna R; Agbandje-McKenna M; Almendral JM
    J Virol; 2006 Feb; 80(3):1563-73. PubMed ID: 16415031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus.
    Truyen U; Geissler K; Parrish CR; Hermanns W; Siegl G
    J Gen Virol; 1998 May; 79 ( Pt 5)():1153-8. PubMed ID: 9603330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine parvovirus in asymptomatic feline carriers.
    Clegg SR; Coyne KP; Dawson S; Spibey N; Gaskell RM; Radford AD
    Vet Microbiol; 2012 May; 157(1-2):78-85. PubMed ID: 22257775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.